Release
📈 Stocks
Brii Biosciences Launches BRiSC Platform to Target Metabolic Diseases
(just now)
Brii Biosciences introduces its BRiSC siRNA platform to expand its therapeutic pipeline, targeting metabolic diseases through advanced dual-targeting medicine development.